FCM
HALO icon

Fieldview Capital Management’s Halozyme HALO Stock Holding History

Fieldview Capital Management’s Portfolio HALO Stock Details HALO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$225K Buy
+2,878
New +$196K 0.06% 462
2025
Q4 		– Sell
-10,705
Closed -$785K – 551
2025
Q3 		$785K Buy
+10,705
New +$711K 0.13% 209

Other funds holding HALO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return

Fieldview Capital Management's HALO Position: Q2 2026 in Review

Fieldview Capital Management opened a new position in Halozyme (HALO) in Q2 2026: 2,878 shares worth $225K. The stake represents 0.06% of the portfolio and ranks #462 among its holdings. This is a return to the name: Fieldview Capital Management previously reported a position in HALO as recently as Q3 2025.

Fieldview Capital Management first reported a position in HALO in Q3 2025 and has held it in 2 quarters since. The position peaked at $785K in Q3 2025. 671 funds tracked by Wall St. Rank hold HALO as of Q2 2026.

  • Fieldview Capital Management held 2,878 shares of Halozyme worth $225K as of Q2 2026.
  • Halozyme was a new Fieldview Capital Management position in Q2 2026.
  • Halozyme made up 0.06% of Fieldview Capital Management's portfolio in Q2 2026, its #462 holding.
  • Fieldview Capital Management first reported a position in Halozyme in Q3 2025 and has held it in 2 quarters since.
  • Fieldview Capital Management's Halozyme position peaked at $785K in Q3 2025.
  • 671 funds tracked by Wall St. Rank held Halozyme as of Q2 2026.

Based on Fieldview Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.